VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways

International Journal of Molecular Medicine

Volumn 29, Issue 2, 2012, Pages 202-208

  Dai, Cong ^a   Zhao, De Hui ^a   Jiang, Min ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Inflammatory bowel disease; Intestinal barrier; MAPKs signaling pathway; Probiotic

Indexed keywords

DEXTRAN SULFATE; MITOGEN ACTIVATED PROTEIN KINASE; PLACEBO; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; VSL3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTESTINAL EPITHELIAL BARRIER; INTESTINE EPITHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ANIMALS; CELL LINE, TUMOR; COLITIS; COLON; DEXTRAN SULFATE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERMEABILITY; PHOSPHOPROTEINS; PROBIOTICS; RATS; RATS, WISTAR; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855162180     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.839     Document Type: Article

References (22)

1. Fuller R: Probiotics in man and animals. J Appl Bacteriol 66: 365-378, 1989.
2. Madsen K, Cornish A, Soper P, et al.: Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591, 2001. (Pubitemid 32822573)
3. Ewaschuk J, Endersby R, Thiel D, et al.: Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46: 841-850, 2007. (Pubitemid 47436131)
4. Qin HL, Shen TY, Gao ZG, et al.: Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World J Gastroenterol 11: 2591-2596, 2005.
5. Diamond JM: Twenty-first Bowditch lecture. The epithelial junction: bridge, gate, and fence. Physiologist 20: 10-18, 1977.
6. van Meer G and Simons K: The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells. EMBO J 5: 1455-1464, 1986.
7. Fanning AS, Jameson BJ, Jesaitis LA and Anderson JM: The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273: 29745-29753, 1998. (Pubitemid 28509986)
8. Boncoeur E, Criq VS, Bonvin E, et al.: Oxidative stress induces extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase in cystic fibrosis lung epithelial cells: potential mechanism for excessive IL-8 expression. Int J Biochem Cell Biol 40: 432-446, 2008. (Pubitemid 351241223)
9. Kyriakis JM and Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869, 2001. (Pubitemid 32267078)
10. 2-terminal kinase signaling. J Pharmacol Exp Ther 326: 949-956, 2008.
11. Dent P, Yacoub A, Fisher PB, Hagan MP and Grant S: MAPK pathways in radiation responses. Oncogene 22: 5885-5896, 2003. (Pubitemid 37176709)
12. Cooper HS, Murthy SN, Shah RS and Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249, 1993.
13. Rijcken EM, Laukoetter MG, Anthoni C, et al.: Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling. Am J Physiol Gastrointest Liver Physiol 287: G115-G124, 2004. (Pubitemid 38802125)
14. Kitajima S, Takuma S and Morimoto M: Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim 48: 137-143, 1999. (Pubitemid 129558679)
15. Ukena SN, Singh A, Dringenberg U, et al.: Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2: e1308, 2007.
16. Anderson RC, Cookson AL, McNabb WC, et al.: Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 10: 316, 2010.
17. Donato KA, Gareau MG, Wang YJ and Sherman PM: Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor- α-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 156: 3288-3297, 2010.
18. Ewaschuk JB, Diaz H, Meddings L, et al.: Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295: G1025-G1034, 2008.
19. Karczewski J, Troost FJ, Konings I, et al.: Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 298: G851-G859, 2010.
20. Mennigen R, Nolte K, Rijcken E, et al.: Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296: G1140-G1149, 2009.
21. Resta-Lenert S and Barrett KE: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52: 988-997, 2003. (Pubitemid 36765291)
22. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U and Schmidt MA: Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9: 804-816, 2007. (Pubitemid 46231983)